120 related articles for article (PubMed ID: 35677441)
1. Characteristics and Predictors of Venous Thromboembolism Among Lymphoma Patients Undergoing Chemotherapy: A Cohort Study in China.
Chen Y; Lei H; Wang W; Zhu J; Zeng C; Lu Z; Li L; Li D; Long B; Liu H
Front Pharmacol; 2022; 13():901887. PubMed ID: 35677441
[No Abstract] [Full Text] [Related]
2. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
Khorana AA; Francis CW; Culakova E; Lyman GH
Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study.
Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Yoon SH; Kim YB
PLoS One; 2021; 16(4):e0250723. PubMed ID: 33909674
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolic events in T-cell lymphoma patients: Incidence, risk factors and clinical features.
Lan Y; Guan J; Zhu J; Wang J; Li M; Sun C; Sun F; Huang J; Lu S; Zhang Y
Leuk Res; 2021 Apr; 103():106537. PubMed ID: 33631621
[TBL] [Abstract][Full Text] [Related]
5. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
Khorana AA; Dalal M; Lin J; Connolly GC
Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
[TBL] [Abstract][Full Text] [Related]
6. Venous Thromboembolism During Chemotherapy for Testicular Cancer: A Population-Based Study.
Robinson AG; Wei X; Karim S; Raphael MJ; Bedard PL; Booth CM
Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):e188-e193. PubMed ID: 32387044
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk of venous thromboembolism according to primary treatment type in women with endometrial cancer: a population-based study.
Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Cho YK; Kim YB
BMC Cancer; 2021 Oct; 21(1):1166. PubMed ID: 34717579
[TBL] [Abstract][Full Text] [Related]
8. D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with Cancer.
Kumar V; Shaw JR; Key NS; Ilich A; Mallick R; Wells PS; Carrier M
Oncologist; 2020 Dec; 25(12):1075-1083. PubMed ID: 32969580
[TBL] [Abstract][Full Text] [Related]
9. Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.
Shi A; Huang J; Wang X; Li M; Zhang J; Chen Y; Huang Y
Urol Oncol; 2018 Jun; 36(6):307.e15-307.e21. PubMed ID: 29599070
[TBL] [Abstract][Full Text] [Related]
10. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study.
Brand JS; Hedayati E; Bhoo-Pathy N; Bergh J; Hall P; Humphreys K; Ludvigsson JF; Czene K
Cancer; 2017 Feb; 123(3):468-475. PubMed ID: 27727456
[TBL] [Abstract][Full Text] [Related]
12. Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population.
Park LC; Woo SY; Kim S; Jeon H; Ko YH; Kim SJ; Kim WS
Thromb Res; 2012 Sep; 130(3):e6-12. PubMed ID: 22507288
[TBL] [Abstract][Full Text] [Related]
13. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
[TBL] [Abstract][Full Text] [Related]
14. Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Kung M; Ness E; Parman M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Cancer; 2019 Dec; 125(24):4498-4508. PubMed ID: 31469420
[TBL] [Abstract][Full Text] [Related]
15. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
[TBL] [Abstract][Full Text] [Related]
16. Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000-2014: A Population-based Cohort Study.
Haugnes HS; Negaard HF; Jensvoll H; Wilsgaard T; Tandstad T; Solberg A
Eur Urol Open Sci; 2021 Oct; 32():19-27. PubMed ID: 34667955
[TBL] [Abstract][Full Text] [Related]
17. Risk of Venous Thromboembolism for Patients with Pancreatic Ductal Adenocarcinoma Undergoing Preoperative Chemotherapy Followed by Surgical Resection.
Boone BA; Zenati MS; Rieser C; Hamad A; Al-Abbas A; Zureikat AH; Hogg ME; Neal MD; Zeh HJ
Ann Surg Oncol; 2019 May; 26(5):1503-1511. PubMed ID: 30652227
[TBL] [Abstract][Full Text] [Related]
18. Incidence of venous thromboembolism and the role of D-dimer as predictive marker in patients with advanced gastric cancer receiving chemotherapy: A prospective study.
Park K; Ryoo BY; Ryu MH; Park SR; Kang MJ; Kim JH; Han S; Kang YK
World J Gastrointest Oncol; 2017 Apr; 9(4):176-183. PubMed ID: 28451065
[TBL] [Abstract][Full Text] [Related]
19. The risk of venous thromboembolism after surgery for esophagogastric malignancy and the impact of chemotherapy: a population-based cohort study.
Adiamah A; Ban L; West J; Humes DJ
Dis Esophagus; 2020 Jun; 33(6):. PubMed ID: 31617892
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for inpatient venous thromboembolism despite thromboprophylaxis.
Wang TF; Wong CA; Milligan PE; Thoelke MS; Woeltje KF; Gage BF
Thromb Res; 2014 Jan; 133(1):25-9. PubMed ID: 24300584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]